Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma

BACKGROUND: There is an urgent need for effective treatment of patients with relapsed/refractory diffuse large B‐cell lymphoma (R/R‐DLBCL). This trial investigated the efficacy of decitabine in combination with rituximab, cisplatin, cytarabine, dexamethasone (RDHAP) in R/R‐DLBCL. METHODS: 56 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Kong, Xiaoshuang, Zhang, Xudong, Ding, Mengjie, Feng, Xiaoyan, Dong, Meng, Zhang, Lei, Fu, Xiaorui, Li, Ling, Li, Xin, Sun, Zhenchang, Yan, Jiaqin, Wang, Xinhua, Wu, Xiaolong, Chen, Qingjiang, Zhang, Mingzhi, Zhu, Linan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134321/
https://www.ncbi.nlm.nih.gov/pubmed/36695162
http://dx.doi.org/10.1002/cam4.5615

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134321/
https://www.ncbi.nlm.nih.gov/pubmed/36695162
http://dx.doi.org/10.1002/cam4.5615

Ejemplares similares